Hyperparathyroidism, an emerging disease
- PMID: 21076902
- DOI: 10.1007/s13304-010-0031-x
Hyperparathyroidism, an emerging disease
Abstract
A retrospective study based on 35 years of personal experience was done. Up to today 2,175 patients were operated, 1,318 for primary hyperparathyroidism (HPT) and 857 for secondary and tertiary HPT. Considering recent years (1999 to July 2010), 918 patients were operated for primary HPT. Preoperatively all the patients performed a cervical ultrasound and/or a sestamibi scan. Open mininvasive procedure was preferred: it is an easily reproducible and costless technique. Using magnifying glasses up to 2.5, an excellent three-dimensional vision was obtained. The operating time is short and if there are any doubts it is possible to extend the exploration to the other side of the neck. Immediate and long-term results were excellent, with a cure rate greater than 99%. Complications in the treatment of a single adenoma are around 0.3%. Patients can be discharged 24-48 h after the operation. Regarding reoperations, a correct diagnostic and therapeutic approach is essential. CT, MRI and SPECT must correlate with the information given by ultrasound and scintigraphy. The intraoperative PTH assay (io-PTH) is required and the approach should be limited to the area where the missed gland probably is. The functionality of the autotransplantation (AT) performed immediately was good. The functionality of the cryopreserved tissue is better for the HPT I in comparison with HPT II. Considering HPT I or HPT II the use of io-PTH is helpful. MIBI scanning is helpful but not essential, except in reoperations. Surgeon experience is another very important factor for good results.
Similar articles
-
Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.Eur J Nucl Med. 2001 Sep;28(9):1351-9. Eur J Nucl Med. 2001. PMID: 11585294
-
The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidism.Ann Surg. 2009 Dec;250(6):868-71. doi: 10.1097/SLA.0b013e3181b0c7f4. Ann Surg. 2009. PMID: 19855263
-
Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low (99m)Tc-MIBI dose. Technical considerations and long-term clinical results.Q J Nucl Med. 2003 Jun;47(2):129-38. Q J Nucl Med. 2003. PMID: 12865873 Clinical Trial.
-
Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism.Arch Surg. 2000 May;135(5):550-5; discussion 555-7. doi: 10.1001/archsurg.135.5.550. Arch Surg. 2000. PMID: 10807279 Review.
-
Radionuclide parathyroid imaging: a concise, updated review.Hell J Nucl Med. 2013 May-Aug;16(2):125-33. doi: 10.1967/s002449910083. Epub 2013 May 20. Hell J Nucl Med. 2013. PMID: 23687643 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources